SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Clinical trial NCT02543476 · COMPLETED

Trial details

NCT number: NCT02543476
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2015-09-16
Primary completion: 2016-11-14
Enrollment: 412

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.